Progression of stroke deficits in patients presenting with mild symptoms: The underlying etiology determines outcome

Background and purpose Patients with acute stroke and mild or rapidly improving symptoms frequently show progression. The role of reperfusion treatment in such patients is not clear. We hypothesized that progression was most likely in patients with cortical localization and such patients may benefit from thrombolysis. Material and methods We interrogated Hamad Stroke Database to evaluate 90-days outcome in patients with acute ischemic stroke admitted within 4 hours and a NIHSS score of ≤6. Evaluation was based on localization (lacunar or cortical), multi-model imaging abnormalities and whether they received rt-PA. The 90-day mRS was used to determine outcome. Results During study period 6381 patients were admitted with acute stroke. Mild stroke within 4 hours was diagnosed in 506 [no thrombolysis: 381(lacunar: 213; cortical: 168), thrombolysis: 125 (lacunar: 45; cortical: 80)]. The rt-PA treated patients had significantly higher NIHSS (2.94±3.9 versus 1.28±2.46, p<0.0001), increased rates of complications (16.0% versus 3.9%, p<0.0001) and longer hospital stay (6.05±8.1 versus 3.78±3.6 days; p<0.001). In patients with cortical stroke, intracranial arterial occlusions (11.6% vs 3.9%, p<0.0001) and CTP mismatch (22.2% vs 4.4%, p<0.0001) were more frequent in rt-PA treated patients. Discharge mRS (33.6% versus 13.9%, p<0.001) and 90-days mRS (23.2% versus 11.8%, p = 0.002) was significantly worse in patients with cortical stroke (rt-PA-treated and untreated patients). Conclusions The outcome in patients with mild stroke depends on lesion location (lacunar versus cortical) and severity of symptoms. Patients who receive rt-PA have significantly larger deficits, increased imaging abnormalities and higher rates of hospital complication, explaining the poor outcome in such subjects.

[1]  Wade S. Smith,et al.  Mechanical Thrombectomy in Patients With Milder Strokes and Large Vessel Occlusions: A Multicenter Matched Analysis , 2018, Stroke.

[2]  Prisms Investigators Effect of alteplase vs aspirin on functional outcome for patients with acute ischemic stroke and minor nondisabling neurologic deficits the PRISMS randomized clinical trial , 2018 .

[3]  Yongjun Cao,et al.  Efficacy and safety of intravenous recombinant tissue plasminogen activator in mild ischaemic stroke: a meta-analysis , 2018, Stroke and Vascular Neurology.

[4]  Sara K. Rostanski,et al.  Door-to-Needle Delays in Minor Stroke: A Causal Inference Approach , 2017, Stroke.

[5]  L. Schwamm,et al.  Baseline Predictors of Poor Outcome in Patients Too Good to Treat With Intravenous Thrombolysis , 2016, Stroke.

[6]  Eric E. Smith,et al.  Why are acute ischemic stroke patients not receiving IV tPA? , 2016, Neurology.

[7]  R. Malik,et al.  Ethnic variation in acute cerebrovascular disease: Analysis from the Qatar stroke registry , 2016, European stroke journal.

[8]  Z. Bhutta,et al.  Stroke Thrombolysis Protocol Shortens "Door-to-Needle Time" and Improves Outcomes-Experience at a Tertiary Care Center in Qatar. , 2016, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[9]  C. Bladin,et al.  Utility of Computed Tomographic Perfusion in Thrombolysis for Minor Stroke , 2016, Stroke.

[10]  Eric E. Smith,et al.  Distinct Short-Term Outcomes in Patients With Mild Versus Rapidly Improving Stroke Not Treated With Thrombolytics , 2016, Stroke.

[11]  P. Sandercock,et al.  Effect of Intravenous Recombinant Tissue-Type Plasminogen Activator in Patients With Mild Stroke in the Third International Stroke Trial-3: Post Hoc Analysis , 2015, Stroke.

[12]  M. Hill,et al.  Should Minor Stroke Patients Be Thrombolyzed? A Focused Review and Future Directions , 2015, International journal of stroke : official journal of the International Stroke Society.

[13]  P. Gorelick,et al.  Comparative effectiveness of standard care with IV thrombolysis versus without IV thrombolysis for mild ischemic stroke. , 2015, Journal of the American Heart Association.

[14]  P. Sandercock,et al.  Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials | NOVA. The University of Newcastle's Digital Repository , 2014 .

[15]  Min Zhang,et al.  Safety and Outcome of Thrombolysis in Mild Stroke: A Meta-Analysis , 2014, Medical science monitor : international medical journal of experimental and clinical research.

[16]  V. Sharma,et al.  Intravenously administered tissue plasminogen activator useful in milder strokes? A meta-analysis. , 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[17]  S. Kiechl,et al.  Thrombolysis in Patients With Mild Stroke: Results From the Austrian Stroke Unit Registry , 2014, Stroke.

[18]  J. S. Lee,et al.  Proximal Arterial Occlusion in Acute Ischemic Stroke with Low NIHSS Scores Should Not Be Considered as Mild Stroke , 2013, PloS one.

[19]  M. Mokin,et al.  Outcomes in patients with acute ischemic stroke from proximal intracranial vessel occlusion and NIHSS score below 8 , 2013, Journal of NeuroInterventional Surgery.

[20]  G. Saposnik,et al.  Validation of minor stroke definitions for thrombolysis decision making. , 2013, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[21]  A. Demchuk,et al.  Refinement of Imaging Predictors of Recurrent Events following Transient Ischemic Attack and Minor Stroke , 2013, PloS one.

[22]  A. Demchuk,et al.  What Causes Disability After Transient Ischemic Attack and Minor Stroke?: Results From the CT And MRI in the Triage of TIA and minor Cerebrovascular Events to Identify High Risk Patients (CATCH) Study , 2012, Stroke.

[23]  M. Elkind,et al.  Too Good to Treat? Outcomes in Patients Not Receiving Thrombolysis Due to Mild Deficits or Rapidly Improving Symptoms , 2012, International journal of stroke : official journal of the International Stroke Society.

[24]  M. Conaway,et al.  Ninety-Day Outcome Rates of a Prospective Cohort of Consecutive Patients With Mild Ischemic Stroke , 2012, Stroke.

[25]  Eric E. Smith,et al.  Outcomes in Mild or Rapidly Improving Stroke Not Treated With Intravenous Recombinant Tissue-Type Plasminogen Activator: Findings From Get With The Guidelines–Stroke , 2011, Stroke.

[26]  S. Levine,et al.  Mild stroke and rapidly improving symptoms: it's not always a happy ending. , 2011, Stroke.

[27]  K. Furie,et al.  Intracranial Large Vessel Occlusion as a Predictor of Decline in Functional Status After Transient Ischemic Attack , 2011, Stroke.

[28]  Pooja Khatri,et al.  Strokes With Minor Symptoms: An Exploratory Analysis of the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Trials , 2010, Stroke.

[29]  J. Kirmani,et al.  Very Mild Stroke Patients Benefit from Intravenous Tissue Plasminogen Activator Without Increase of Intracranial Hemorrhage , 2010, Southern medical journal.

[30]  Gerhard Schroth,et al.  What Is a Minor Stroke? , 2010, Stroke.

[31]  J. Berg,et al.  Why ischemic stroke patients do not receive thrombolytic treatment: results from a general hospital , 2009, Acta neurologica Scandinavica.

[32]  J. S. P. van den Berg,et al.  Why ischemic stroke patients do not receive thrombolytic treatment: results from a general hospital , 2009, Acta neurologica Scandinavica.

[33]  A. Demchuk,et al.  Recurrent Events in Transient Ischemic Attack and Minor Stroke: What Events Are Happening and to Which Patients? , 2008, Stroke.

[34]  G. Schroth,et al.  Outcome of Stroke With Mild or Rapidly Improving Symptoms , 2007, Stroke.

[35]  Jeffery R. Alger,et al.  Early MRI and outcomes of untreated patients with mild or improving ischemic stroke , 2006, Neurology.

[36]  Eric E. Smith,et al.  Poor Outcomes in Patients Who Do Not Receive Intravenous Tissue Plasminogen Activator Because of Mild or Improving Ischemic Stroke , 2005, Stroke.

[37]  J. Martí-Fàbregas,et al.  Reasons for exclusion from thrombolytic therapy following acute ischemic stroke , 2005, Neurology.

[38]  A. Demchuk,et al.  Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. , 2001 .

[39]  A. Demchuk,et al.  Why are stroke patients excluded from TPA therapy? , 2001, Neurology.